GENOME ANNOUNCEMENT
===================

Methicillin-resistant *Staphylococcus aureus* (MRSA) is among the most frequently identified antimicrobial drug-resistant pathogens worldwide. It has been demonstrated that some lineages are ecologically highly successful and that most isolates belong to pandemic clones ([@B1]). In Spain, *S. aureus* sequence type ST125 continues to be responsible for more than half of the nosocomial MRSA infections ([@B2]). With increasing pressure to prevent MRSA infection, it is possible that there will be increased use of mupirocin for nasal decolonization of MRSA ([@B3]), which will be reflected in increased rates of resistance ([@B4]). High-level mupirocin resistance (Hi-Mup^R^) (MICs of ≥512 μg/ml) is mediated by acquisition of a novel isoleucyl-tRNA synthetase gene (*mup*A or *ileS*2) on a transferable plasmid, which could carry multiple resistance determinants for other classes of antimicrobial agents ([@B3]).

*S*. *aureus* ST125 was the most prevalent MRSA strain (83.3%) in our institution. We detected 8.8% Hi-Mup^R^ among MRSA isolates, and most of this resistance was focused on the ST125 clone ([@B5]). The *S. aureus* SA_ST125_MupR strain was isolated from an adult patient with recurrent bacteremia. This strain was characterized as pulsed-field gel electrophoresis pattern type E8, *spa* type t1399, *agr* type II, and staphylococcal cassette chromosome *mec* element (SCC*mec*) type IVc ([@B6]).

Genomic DNA was extracted from an overnight culture using the DNeasy blood and tissue kit (Qiagen) after addition of lysostaphin (100 μg/ml) and incubation at 37°C for 2 h. The *S. aureus* SA_ST125_MupR genome was sequenced by using the 454 GS-Junior platform (Roche), generating 196,055 reads, for a total of 91,441,914 bp, with 29-fold average coverage. With the Newbler Assembler v2.7 (Roche), the obtained sequences were *de novo* assembled into 49 contigs with an *N*~50~ contig size of 192,317 nucleotides and a total length of 2,852,031 bp. The average G+C content was 32.7%. Sequences were annotated using the NCBI Prokaryotic Genomes Automatic Annotation Pipeline (PGGAP) (<http://www.ncbi.nlm.nih.gov/genome/annotation_prok/>), yielding a total of 2,757 genes, 2,664 coding DNA sequence (CDS) genes, 26 pseudogenes, 58 tRNAs, and 9 rRNAs. Furthermore, the Rapid Annotations using Subsystems Technology (RAST) (<http://rast.nmpdr.org>) server ([@B7]) and Comprehensive Antibiotic Resistance Database (CARD) (<http://arpcard.mcmaster.ca>) ([@B8]) were used. There were genes related to antibiotic resistance and toxic compounds. These included efflux pumps (ATP-binding cassette \[ABC\] transporter, major facilitator superfamily, small multidrug resistance) potentially carrying resistance to a wide range of antimicrobials (fluoroquinolones, tetracyclines, and macrolides), and genes associated with specific resistance to β-lactams (*mec*A, *mec*R1, *mpr*F, *bla*Z, *bla*I, and *bla*R), aminoglycosides (phosphotransferases, adenyltransferases, and nucleotidyltransferases), macrolides/lincosamides/streptogramins (*mph*, *mac*B), fosfomycin (*fos*B), tetracycline (*tet*M), rifampin (*dna*A), glycopeptides (*ble*O), and mupirocin (*ile*S, *ile*S2), as well as resistance determinants to arsenic, cadmium, cobalt, mercury, and zinc. The *ile*S2 gene was located on a plasmid which was partially sequenced, giving a final size of \~58 kb, and it harbored other genes associated with resistance to β-lactams and macrolides. Overall, the availability of the present genome sequences facilitates further comparative genomic and bioinformatic analysis in *S. aureus* populations and may also provide insights into the genetic background for the success of this nosocomial lineage.

Nucleotide sequence accession number. {#h1}
-------------------------------------

This whole-genome shotgun project has been deposited at GenBank under the accession number [ASTH00000000](ASTH00000000).
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